Pfizer submits data to authorise Covid vaccine in young children

Share on facebook
Share on twitter
Share on email
Share on whatsapp

WASHINGTON: Pfizer and BioNTech said Tuesday they had begun submitting data to the United States Food and Drug Administration for the highly anticipated authorisation of their Covid-19 vaccine in children aged 5 to 11.

© New Straits Times Press (M) Bhd